A Randomized Double-Blind Placebo Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Botulinum Neurotoxin Type A in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder.
Phase of Trial: Phase II/III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache disorders
- Focus Adverse reactions; Therapeutic Use
- 11 May 2011 New trial record